Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Boehringer Ingelheim Animal Health Denmark A / S, filial Sverige
FL
Active
Org 5164111436
Virdings Allé 8, 754 50
Uppsala
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2017 · 8 years old
10-19 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Boehringer Ingelheim Animal Health Denmark A / S, filial Sverige
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (4)
SM
Stephen Mark Wright
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
NR
Niko Rodio
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
JG
Jimmy Gustav Almqvist
Chief Auditor
Chief Auditor
2025
DN
Dirk Neven Rauleder
Chief Executive Officer
Chief Executive Officer
2025
Former (2)
LM
Lars Mikael Käll
Chief Auditor
Chief Auditor
2022 – 2025
NB
Niels Berenth From
Chief Executive Officer
Chief Executive Officer
2022 – 2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Boehringer Ingelheim Animal Health Denmark A / S, filial Sverige
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
